Company intelligence / Profile preview

Guangxi Baoruitan Pharmaceutical

Nanning, Guangxi, China

Ownership: Private
Development stage: Other

Overview

Guangxi Baoruitan Pharmaceutical is a specialized pharmaceutical company based in Nanning, China, focused on the development and production of dermatological treatments. The company is primarily recognized for its flagship product, Imiquimod cream, which is used as an immune response modifier for conditions such as external genital warts and certain skin cancers. Baoruitan operates modern, GMP-certified manufacturing facilities dedicated to topical formulations and small molecule synthesis. As a recognized high-tech enterprise, the company integrates research, production, and sales to serve the domestic Chinese healthcare market.

Therapeutic areas: OncologyDermatologyInfectious Diseases
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Guangxi Baoruitan Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guangxi Baoruitan Pharmaceutical.

Explore the full profile